A comprehensive view of GSK Group (GlaxoSmithKline). This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GlaxoSmithkline Biologicals Seeks Patent for Adjuvants
Published: April 13, 2024 by Pharmaceutical Patent News
GlaxoSmithKline Consumer Healthcare Holdings US Files European Patent Application for Dosage Form for Nicotine Replacement Therapy
Published: April 13, 2024 by Pharmaceutical Patent News
Patent Application Titled 'Immunogenic Composition' Published Online (USPTO 20240100140)
Published: April 12, 2024 by NewsRx Pharma Business Daily
GSK Group Advocates for a #StrongerPBS to Expedite Access to Medicines in Australia, Highlighting Industry Impact
Published: April 10, 2024 by Industry Intelligence Inc.
Goldman Sachs identifies 11 European stocks that are a solid alternative for 'Magnificent 7' tech stocks in US; dubbed 'Granolas,' these EU stocks have contributed over 50% of STOXX 600 returns in 2023, and include Novo Nordisk, Nestle, LVMH, GSK, Roche
Published: April 08, 2024 by The Straits Times

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count